We’re thrilled to introduce a suite of new innovative features in the Climedo platform, designed to enhance the efficiency, user experience and global reach of clinical trials. These updates empower patients, investigators and sponsors with tools that streamline workflows, boost engagement and improve data quality. Here’s a closer look at what’s new: Decentralized Clinical Trials […] The post Exciting New Climedo Features to Enhance Hybrid Trials and ePRO Workflows appeared first on Climedo ..read more

As 2024 draws to a close, it’s time to look back at Climedo’s most popular content of the year. Through our webinars, whitepapers and other publications, we have once again been able to connect many people. At a total of seven webinars with renowned speakers, we were able to learn more about the constantly evolving […] The post 2024 in Review: Our Top Content and Climedo Connect Webinars appeared first on Climedo ..read more

Introduction Real-World Evidence (RWE) studies rely heavily on a diverse stream of data sources to draw meaningful conclusions. Despite its value, much of this data remains unstructured, creating major challenges for researchers and pharmaceutical companies. Unstructured data, like clinical notes, patient feedback and records from external databases, often exist in formats that are difficult to […] The post From Chaos to Clarity: Using GenAI to Structure Unstructured Data in RWE Studies appeared first on Climedo ..read more

“I want a doctor who takes a little time to explain (things) to you, one who shows a little empathy.” “I started crying because I couldn’t handle it. And then as an afterthought, he (the doctor) said, ‘Yeah, I’m sorry this is bad news’.” “The doctor was very practical but totally unempathetic.” “Sometimes the patient […] The post A New Era of Empathy in Patient Interactions appeared first on Climedo ..read more

Health technology assessment (HTA) aims to provide a comprehensive evidence base to inform decisions about which medical treatments, devices and health interventions should be adopted and funded within a healthcare system. While quantitative data from clinical trials and economic modelling is crucial, qualitative research is increasingly recognized as an essential complementary component of robust HTA. […] The post The Role of Qualitative Research in Health Technology Assessment (HTA) appeared first on Climedo ..read more

Health Technology Assessment (HTA) is a multidisciplinary process that systematically evaluates the clinical, economic, ethical and societal implications of introducing new health technologies. At its core, HTA aims to inform decision-making by providing comprehensive evidence on the potential impacts of adopting a new technology within a healthcare system. While HTA draws upon various research methodologies, […] The post The Role of Quantitative Research in Health Technology Assessment appeared first on Climedo ..read more

Health technology assessment (HTA) aims to provide a comprehensive evidence base to inform decisions about which medical treatments, devices and health interventions should be adopted and funded within a healthcare system. While quantitative data from clinical trials and economic modelling is crucial, qualitative research is increasingly recognized as an essential complementary component of robust HTA. Qualitative research employs methods like interviews, focus groups, observations and textual analysis to explore phenomena in depth – seeking insights into perspectives, motivations, contexts an ..read more

The following is a transcript of a joint webinar with Hendrik Stork (IQVIA) which was hosted by Climedo on March 13, 2024.*  Introduction Welcome, everyone. Today, we will explore the realm of real-world data (RWD) and evidence (RWE), breaking it down into four main buckets:  1. What is Real-World Data? 2. Why Real-World Data and Evidence? 3. How to access Real-World Data 4. Driving Evidence-Based Decision Making We’ll focus specifically on RWD within the context of the healthcare system, steering clear of other industries where RWD may hold different significance. 1. What is Real-Wo ..read more

Introduction Generative Artificial Intelligence (GenAI) has emerged as a transformative force in various industries, including healthcare and pharmaceutical research. This technology offers the capability to create new content based on machine learning models. In this blog post, we will dive into the realm of the potential of GenAI, exploring its potential in Real-World Evidence (RWE) studies. We will look at the benefits, challenges and promising use cases of GenAI in RWE studies, shedding light on how it can revolutionize the way clinical trials are conducted.  Additionally, we will dis ..read more

In May of 2023, we hosted a 60-minute fireside chat with Paul Petraro on best practices for holistic Real-World Evidence. Paul works as an Executive Director and Global Heads in RWE at the Analytic Evidence Center at Boehringer Ingelheim, where he ensures the management and oversight of real-world studies along with developing RWE strategies. As a trained epidemiologist with a strong background in epidemiology methods and evidence, he is experienced in observational and experimental studies, fast authorization and risk management. Paul also has an in-depth knowledge of public and private epide ..read more